TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transfer

Science Translational Medicine

Volumn 5, Issue 192, 2013, Pages

  Nauerth, Magdalena ^a   Weißbrich, Bianca ^a   Knall, Robert ^a   Franz, Tobias ^a   Dössinger, Georg ^a   Bet, Jeannette ^a   Paszkiewicz, Paulina J ^a   Pfeifer, Lukas ^a   Bunse, Mario ^b,c   Uckert, Wolfgang ^b,c   Holtappels, Rafaela ^d   Gillert Marien, Dorothea ^d   Neuenhahn, Michael ^a,e   Krackhardt, Angela ^a   Reddehase, Matthias J ^d,f   Riddell, Stanley R ^a,g,h   Busch, Dirk H ^a,e  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e DZIF National Centre for Infection Research   (Germany)

^f HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^g Fred Hutchinson Cancer Research Center   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELL SELECTION; CELL SPECIFICITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE MODEL; DISSOCIATION; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMAN; HUMAN CELL; IN VIVO STUDY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROSCOPY; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; RECEPTOR BINDING; RELIABILITY; T LYMPHOCYTE SUBPOPULATION; ANIMAL; CELL CULTURE; GENE; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; PROCEDURES;

ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; GENES, MHC CLASS I; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; MICE; RECEPTORS, ANTIGEN, T-CELL;

EID: 84880557972     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005958     Document Type: Article

References (30)

1. A. Schmitt, T. Tonn, D. H. Busch, G. U. Grigoleit, H. Einsele, M. Odendahl, L. Germeroth, M. Ringhoffer, S. Ringhoffer, M. Wiesneth, J. Greiner, D. Michel, T. Mertens, M. Rojewski, M. Marx, S. von Harsdorf, H. Döhner, E. Seifried, D. Bunjes, M. Schmitt, Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation. Transfusion 51, 591-599 (2011).
2. E. A. Walter, P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, S. R. Riddell, Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038-1044 (1995).
3. M. E. Dudley, J. R. Wunderlich, P. F. Robbins, J. C. Yang, P. Hwu, D. J. Schwartzentruber, S. L. Topalian, R. Sherry, N. P. Restifo, A. M. Hubicki, M. R. Robinson, M. Raffeld, P. Duray, C. A. Seipp, L. Rogers-Freezer, K. E. Morton, S. A. Mavroukakis, D. E. White, S. A. Rosenberg, Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850-854 (2002).
4. M. E. Dudley, J. R. Wunderlich, J. C. Yang, R. M. Sherry, S. L. Topalian, N. P. Restifo, R. E. Royal, U. Kammula,D. E. White, S. A.Mavroukakis, L. J. Rogers,G. J. Gracia, S. A. Jones, D. P. Mangiameli, M. M. Pelletier, J. Gea-Banacloche, M. R. Robinson, D. M. Berman, A. C. Filie, A. Abati, S. A. Rosenberg, Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 23, 2346-2357 (2005).
5. H. J. Kolb, A. Schattenberg, J. M. Goldman, B. Hertenstein, N. Jacobsen, W. Arcese, P. Ljungman, A. Ferrant, L. Verdonck, D. Niederwieser, F. van Rhee, J. Mittermueller, T. de Witte, E. Holler, H. Ansari; European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia, Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86, 2041-2050 (1995).
6. M. Derby, M. Alexander-Miller, R. Tse, J. Berzofsky, High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J. Immunol. 166, 1690-1697 (2001).
7. V. Dutoit, V. Rubio-Godoy, P. Y. Dietrich, A. L. Quiqueres, V. Schnuriger, D. Rimoldi, D. Liénard, D. Speiser, P. Guillaume, P. Batard, J. C. Cerottini, P. Romero, D. Valmori, Heterogeneous T-cell response to MAGE-A10254-262: High avidity-specific cytolytic T lymphocytes show superior antitumor activity. Cancer Res. 61, 5850-5856 (2001).
8. H. J. Zeh III, D. Perry-Lalley, M. E. Dudley, S. A. Rosenberg, J. C. Yang, High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J. Immunol. 162, 989-994 (1999).
9. T. M. Clay, M. C. Custer, J. Sachs, P. Hwu, S. A. Rosenberg, M. I. Nishimura, Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J. Immunol. 163, 507-513 (1999).
10. R. A. Morgan, M. E. Dudley, Y. Y. Yu, Z. Zheng, P. F. Robbins, M. R. Theoret, J. R. Wunderlich, M. S. Hughes, N. P. Restifo, S. A. Rosenberg, High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens. J. Immunol. 171, 3287-3295 (2003).
11. Y. Zhao, Z. Zheng, P. F. Robbins, H. T. Khong, S. A. Rosenberg, R. A. Morgan, Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines. J. Immunol. 174, 4415-4423 (2005).
12. S. Wilde, D. Sommermeyer, B. Frankenberger, M. Schiemann, S. Milosevic, S. Spranger, H. Pohla, W. Uckert, D. H. Busch, D. J. Schendel, Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity. Blood 114, 2131-2139 (2009).
13. L. A. Johnson, B. Heemskerk, D. J. Powell Jr., C. J. Cohen, R. A. Morgan, M. E. Dudley, P. F. Robbins, S. A. Rosenberg, Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes. J. Immunol. 177, 6548-6559 (2006).
14. D. H. Busch, E. G. Pamer, T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189, 701-710 (1999).
15. D. S. Lyons, S. A. Lieberman, J. Hampl, J. J. Boniface, Y. Chien, L. J. Berg, M. M. Davis, A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5, 53-61 (1996).
16. X. L. Wang, J. D. Altman, Caveats in the design of MHC class I tetramer/antigen-specific T lymphocytes dissociation assays. J. Immunol. Methods 280, 25-35 (2003).
17. M. Knabel, T. J. Franz, M. Schiemann, A. Wulf, B. Villmow, B. Schmidt, H. Bernhard, H. Wagner, D. H. Busch, Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat. Med. 8, 631-637 (2002).
18. J. D. Altman, P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, M. M. Davis, Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96 (1996).
19. J. B. Walter, D. N. Garboczi, Q. R. Fan, X. Zhou, B. D. Walker, H. N. Eisen, A mutant human b2- microglobulin can be used to generate diverse multimeric class I peptide complexes as specific probes for T cell receptors. J. Immunol. Methods 214, 41-50 (1998).
20. K. C. Garcia, M. D. Tallquist, L. R. Pease, A. Brunmark, C. A. Scott, M. Degano, E. A. Stura, P. A. Peterson, I. A. Wilson, L. Teyton, ab T cell receptor interactions with syngeneic and allogeneic ligands: Affinity measurements and crystallization. Proc. Natl. Acad. Sci. U.S.A. 94, 13838-13843 (1997).
21. M. A. Alexander-Miller, G. R. Leggatt, J. A. Berzofsky, Selective expansion of high- or lowavidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl. Acad. Sci. U.S.A. 93, 4102-4107 (1996).
22. D. M. Kranz, D. H. Sherman, M. V. Sitkovsky, M. S. Pasternack, H. N. Eisen, Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antisera. Proc. Natl. Acad. Sci. U.S.A. 81, 573-577 (1984).
23. M. A. Purbhoo, J. M. Boulter, D. A. Price, A. L. Vuidepot, C. S. Hourigan, P. R. Dunbar, K. Olson, S. J. Dawson, R. E. Phillips, B. K. Jakobsen, J. I. Bell, A. K. Sewell, The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor z chain. J. Biol. Chem. 276, 32786-32792 (2001).
24. Q. Ouyang, W. M. Wagner, A. Wikby, S. Walter, G. Aubert, A. I. Dodi, P. Travers, G. Pawelec, Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J. Clin. Immunol. 23, 247-257 (2003).
25. S. R. Hadrup, J. Strindhall, T. Køllgaard, T. Seremet, B. Johansson, G. Pawelec, P. thor Straten, A. Wikby, Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 176, 2645-2653 (2006).
26. R. Holtappels, C. O. Simon, M. W. Munks, D. Thomas, P. Deegen, B. Kühnapfel, T. Däubner, S. F. Emde, J. Podlech, N. K. Grzimek, S. A. Oehrlein-Karpi, A. B. Hill, M. J. Reddehase, Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination. J. Virol. 82, 5781-5796 (2008).
27. S. Ebert, J. Podlech, D. Gillert-Marien, K. M. Gergely, J. K. Büttner, A. Fink, K. Freitag, D. Thomas, M. J. Reddehase, R. Holtappels, Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection. Med. Microbiol. Immunol. 201, 527-539 (2012).
28. B. Engels, H. Cam, T. Schüler, S. Indraccolo, M. Gladow, C. Baum, T. Blankenstein, W. Uckert, Retroviral vectors for high-level transgene expression in T lymphocytes. Hum. Gene Ther. 14, 1155-1168 (2003).
29. W. Uckert, C. Becker, M. Gladow, D. Klein, T. Kammertoens, L. Pedersen, T. Blankenstein, Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype. Hum. Gene Ther. 11, 1005-1014 (2000).
30. R. Holtappels, D. Thomas, J. Podlech, M. J. Reddehase, Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype. J. Virol. 76, 151-164 (2002).